These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11035553)

  • 1. Utility-based estimates of the relative morbidity of visual impairment and angina.
    Nease RF; Whitcup SM; Ellwein LB; Fox G; Littenberg B
    Ophthalmic Epidemiol; 2000 Sep; 7(3):169-85. PubMed ID: 11035553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility assessment among patients with dry eye disease.
    Schiffman RM; Walt JG; Jacobsen G; Doyle JJ; Lebovics G; Sumner W
    Ophthalmology; 2003 Jul; 110(7):1412-9. PubMed ID: 12867401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of vision-related quality of life in an older population subsample: The Blue Mountains Eye Study.
    Chia EM; Mitchell P; Ojaimi E; Rochtchina E; Wang JJ
    Ophthalmic Epidemiol; 2006 Dec; 13(6):371-7. PubMed ID: 17169850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK
    Trans Am Ophthalmol Soc; 1996; 94():919-1028. PubMed ID: 8981717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey.
    Nirmalan PK; Tielsch JM; Katz J; Thulasiraj RD; Krishnadas R; Ramakrishnan R; Robin AL
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2308-12. PubMed ID: 15980215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.
    Brown MM; Brown GC; Sharma S; Busbee B
    Ophthalmology; 2003 Jun; 110(6):1076-81. PubMed ID: 12799229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for diabetic retinopathy health States.
    Szabo SM; Beusterien KM; Pleil AM; Wirostko B; Potter MJ; Tildesley H; Gonder J; Barsdorf A; Levy AR
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3387-94. PubMed ID: 20053977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study.
    Klein BE; Moss SE; Klein R; Lee KE; Cruickshanks KJ
    Ophthalmology; 2003 Apr; 110(4):644-50. PubMed ID: 12689880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing patient utilities for varying degrees of low back pain.
    Lai KC; Provenzale JM; Delong D; Mukundan S
    Acad Radiol; 2005 Apr; 12(4):467-74. PubMed ID: 15831420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
    Submacular Surgery Trials Research Group
    Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25.
    Stelmack JA; Stelmack TR; Massof RW
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2859-68. PubMed ID: 12202503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults.
    Owsley C; McGwin G
    Ophthalmology; 2004 Dec; 111(12):2259-64. PubMed ID: 15582083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in glaucoma: what drives utility? Results from a pilot study in Sweden.
    Kobelt G; Jonsson B; Bergström A; Chen E; Lindén C; Alm A
    Acta Ophthalmol Scand; 2006 Jun; 84(3):363-71. PubMed ID: 16704699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma patients' assessment of their visual function and quality of life.
    Jampel HD
    Trans Am Ophthalmol Soc; 2001; 99():301-17. PubMed ID: 11797316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of visual impairment on functional vision of children in rural South India: the Kariapatti Pediatric Eye Evaluation Project.
    Nirmalan PK; John RK; Gothwal VK; Baskaran S; Vijayalakshmi P; Rahmathullah L;
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3442-5. PubMed ID: 15452047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring low vision service outcomes: Rasch analysis of the seven-item National Eye Institute Visual Function Questionnaire.
    Ryan B; Court H; Margrain TH
    Optom Vis Sci; 2008 Feb; 85(2):112-21. PubMed ID: 18296928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.